- 专利标题： Methods for the treatment of hepatitis B and hepatitis D infections
-
申请号： US14449173申请日： 2014-08-01
-
公开(公告)号： US09200283B2公开(公告)日： 2015-12-01
- 发明人: Michel Bazinet , Andrew Vaillant
- 申请人： Replicor Inc
- 代理机构： Norton Rose Fulbright Canada LLP
- 主分类号： C12N15/113
- IPC分类号： C12N15/113 ; A61K38/21 ; A61K45/06 ; A61K31/519 ; A61K39/42 ; A61K31/7088 ; A61K38/22 ; A61K31/566 ; A61K31/7105 ; A61K31/713
摘要：
It is disclosed a method for the treatment of hepatitis B (HBV) infection or HBV/hepatitis D (HDV) co-infection, the method comprising administering to a subject in need of treatment a first pharmaceutically acceptable agent that removes the hepatitis B surface antigen from the blood and a second pharmaceutically acceptable agent which stimulates immune function.
公开/授权文献
信息查询
IPC分类:
